American Red Cross and Haemonetics Settle Contract Dispute.BRAINTREE, Mass.--(BW HealthWire)--July 28, 1998--The American Red Cross American Red Cross: see Red Cross. and Haemonetics Corporation (NYSE NYSE See: New York Stock Exchange :HAE) announced jointly today that The American Red Cross and Haemonetics have settled contract litigation. The parties' dispute concerned contracts entered into in the early 1990s for the provision of pheresis pheresis /phe·re·sis/ (fe-re´sis) apheresis. phe·re·sis n. Apheresis. pheresis any procedure in which blood is withdrawn from a donor, a portion (plasma, leukocytes, etc. equipment used in Red Cross blood centers. The terms of settlement are confidential. "The Red Cross is pleased that we have reached an agreement with Haemonetics," stated Brian McDonough, Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Red Cross Blood Services. "We look forward to working with Haemonetics to explore the potential benefits that Haemonetics' technology can provide Red Cross Blood Services and, ultimately, the patients who rely on us."
CONTACT: Haemonetics Corporation
Lisa Lopez
(781) 356-9517
Investor@Haemonetics.com
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion